China’s HC Scientific has bagged 300 million yuan ($41.2 million) in an extended Series B financing round co-led by Lake Bleu Capital, a Hong Kong-based investment firm that specialises in healthcare investing primarily in the Greater China region.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
